Skip to content

the effect of Triphala Varti in Parikartika

A CONTROL STUDY TO EVALUATE THE EFFECT OF TRIPHALA VARTI (ANAL SUPPOSITORY) AND DICLOFENAC SUPPOSITORY IN THE MANAGEMENT OF PARIKARTIKA (FISSURE IN ANO) - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/086049
Enrollment
60
Registered
2025-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K603- Anal fistula

Interventions

None listed

Sponsors

DR PRINCE KIRTONIA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient will be selected in the age group between 20-50 years Patients with classical sign and symptoms of Parikartika (Parikartanvat Vedana Daha Sarakta-mala-pravrutti Vatasangha Malastambha)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Reduction in Pain (Guda Gata Vedana) Score using Visual Analog Scale (VAS) Reduction in Ulceration Size in the Anal RegionTimepoint: 7th day 14th day 21th day 28th day

Secondary

MeasureTime frame
Reduction in Burning Sensation (Guda Gata Daha) Improvement in Bleeding per Rectum (Guda Gata Rakta Srava) Overall Healing Rate of Anal UlcerTimepoint: Day 7, Day 14, Day 28 (Follow-up)

Countries

India

Contacts

Public ContactDR SUJATA WADDAR

SIDRAMAPPA DANIGOND MEMORIAL TRUSTS AYURVEDIC MEDICAL COLLEGE TERDAL

sujata.bw@gmail.com09424458435

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026